DermaRite Expands Recall of Creams and Sanitizers Over Infection Risk
Products may be contaminated with bacteria that can cause serious infectionsContinue Reading
Products may be contaminated with bacteria that can cause serious infectionsContinue Reading
WEDNESDAY, Sept. 3, 2025 (HealthDay News) — The weight-loss drug Wegovy may lower the risk of heart attack, stroke or death more than similar medications, according to new research from its maker, Novo Nordisk. In a study of more than 21,000 patients with obesity and heart disease but no diabetes,Continue Reading
Wrong dressing packets that were included contain undeclared sesame and soyContinue Reading
WEDNESDAY, Sept. 3, 2025 (HealthDay News) — One of the most effective medications for treating opioid addiction is still hard to find at U.S. pharmacies, according to a new study. Only 2 in 5 retail pharmacies carried buprenorphine in 2023, researchers reported Sept. 2 in the journal Health Affairs. AndContinue Reading
WEDNESDAY, Sept. 3, 2025 (HealthDay News) — A single dose of RSV vaccine might protect seniors for two cold and flu seasons in a row, a new study says. Vaccination reduced seniors’ risk of hospitalization by 58% during two RSV seasons, researchers reported Aug. 30 in the Journal of theContinue Reading
WEDNESDAY, Sept. 3, 2025 (HealthDay News) — Many people with suicidal thoughts are turning to artificial intelligence (AI) chatbots for comfort and advice, and these programs might not be completely up to the challenge, a new study says. Chatbots respond appropriately when asked questions that reflect a very low orContinue Reading
WEDNESDAY, Sept. 3, 2025 (HealthDay News) — The diabetes drug metformin has been a mystery for more than six decades. The most prescribed diabetes med in the world, metformin is very effective in lowering blood sugar levels. But no one knows exactly how it works. But a new study shedsContinue Reading
WEDNESDAY, Sept. 3, 2025 (HealthDay News) — A drug commonly prescribed to heart attack survivors may not benefit many of them, a new clinical trial has found. Beta-blockers do not appear to reduce the risk of death, a second heart attack or heart failure in people’s whose hearts weren’t damagedContinue Reading
Leqembi Iqlik allows for at-home maintenance dosing after initial 18 months of intravenous dosingContinue Reading
TUESDAY, Sept. 2, 2025 (HealthDay News) — The U.S. Centers for Disease Control and Prevention (CDC) is entering a transition period as Jim O’Neill, deputy secretary at the Department of Health and Human Services (HHS), steps in as acting director. The announcement came in a letter to CDC employees fromContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.